Insurance Amendment Bill 2026 Cycle in India: Composite Licence, FDI Changes, Distribution Rules, and the Broker Firm Implications

The Indian insurance statutory framework rests on three primary pieces of legislation: the Insurance Act, 1938, the General Insurance Business (Nationalisation) Act, 1972, and the Insurance Regulatory and Development Authority Act, 1999. Several smaller statutes touch the sector, but the policy direction of the industry is set by the periodic amendments to this core framework. The 2025 cycle of the Insurance Amendment Bill, addressed in a companion post on this site, focused on a specific set of changes that have since progressed through parliamentary stages with adjustments along the way. The 2026 cycle introduces a further set of proposals, some of which extend the 2025 directions and some of which open new policy questions.

The 2026 cycle, based on the Bill text circulated for consultation and the parliamentary committee discussions through 2025-2026, includes provisions on a composite insurance licence permitting a single insurer to write life, non-life, and health business under one entity; further calibration of the foreign direct investment limits in insurance companies and intermediaries; revisions to the distribution rule structure including the agent and broker licensing regimes; expansion of the Insurance Ombudsman scheme with additional benches and increased pecuniary jurisdiction; and procedural updates to align with the Digital Personal Data Protection Act, 2023 and other intersecting regulatory frameworks. The Bill is at the parliamentary committee stage in 2026, with passage and notification timelines depending on the legislative session schedule and the resolution of consultation feedback.

This article examines the implications of these provisions for Indian broker firms, with particular attention to commercial broking where the strategic stakes are highest. The analysis assumes the broad shape of the Bill as currently circulated; specific provisions may evolve through the parliamentary process, and broker leadership teams should track the official Bill text and committee reports for definitive positions. Where this article makes implementation recommendations, the actions are calibrated to be durable against likely variations in the final text rather than dependent on specific clause wording.

The composite licence proposal is the most strategically consequential element of the 2026 cycle. Under the current Insurance Act framework, an insurer is licensed for life business, for non-life business (general insurance), or for standalone health business, and cannot combine these in a single corporate entity. Group structures have multiple insurer subsidiaries to cover the range; integrated customer offerings require operational coordination across separately licensed entities. The composite licence proposal would permit a single insurer to be licensed across all three categories, subject to capital, governance, and operational ringfencing requirements designed to protect the integrity of each business line.

The rationale for composite licensing is partly about consumer experience (a single insurer relationship rather than fragmented across subsidiaries), partly about operational efficiency (shared technology, distribution, and corporate functions), and partly about regulatory alignment with international practice in markets where composite insurance has long been the norm. The counter-arguments emphasise the risk of contagion across business lines with different risk profiles, the supervisory complexity of overseeing composite insurers, and the consumer protection considerations around cross-selling.

1. Implications for the structure of broking firms. Indian broker firms are currently structured as composite intermediaries, which is to say a single broker firm can place life, non-life, and health business under its IRDAI broker licence. The composite licence on the insurer side will not directly change the broker structure, but it will change the insurer market structure that brokers interact with. Brokers should expect that several large group structures will eventually consolidate their separately licensed life, non-life, and health subsidiaries into composite insurers, reducing the number of distinct insurer relationships brokers maintain while increasing the depth of each relationship. The consolidation timeline will depend on the specific transition provisions in the Bill and on commercial decisions by the insurance groups; a multi-year transition is likely.
2. Cross-product distribution economics. Composite insurers will have natural incentives to encourage cross-selling across product lines through their distribution networks, and brokers will be both targets and channels for this cross-selling activity. Commercial brokers should plan for incremental conversations with insurers about life and group benefits products alongside the non-life commercial covers that have historically been the focus of commercial broking activity. The economic question for the broker is whether the broker invests in the cross-product capability or operates with cross-product specialists in partnership.
3. Underwriting integration risk. One operational risk of composite insurance for commercial clients is integrated underwriting that aggregates risk exposures across product lines for a single client. A commercial client with significant property exposure and group health enrolment might face combined underwriting evaluations that affect terms in either line. Brokers should monitor whether composite insurers move toward integrated underwriting and should advise commercial clients on the implications for placement strategy, including the option of splitting product lines across insurers to preserve underwriting independence.

The composite licence is not expected to be a near-term operational change for the broker community, but it is a directional shift that should influence broker strategic planning for the next five to ten years. The companion analysis on FDI changes covers an interconnected dimension that often moves in conjunction with composite licensing in market reforms internationally.

The foreign direct investment limits in Indian insurance have evolved through successive amendments. The 2025 cycle, addressed in the companion post on the 2025 Amendment Bill impact, took FDI in insurance companies to 100 percent under conditions, building on the earlier liberalisation to 74 percent. The 2026 cycle introduces refinements to the FDI framework rather than headline changes to the cap, but several of the refinements are commercially material for broker firms.

1. FDI in intermediaries. The 2026 cycle includes provisions on the FDI framework for insurance intermediaries including brokers, corporate agents, surveyors, and TPAs, with revisions to the conditions under which foreign-owned intermediaries can operate in India. The current framework permits 100 percent FDI in insurance intermediaries subject to specific conditions on Indian management, capital, and operating arrangements. The 2026 revisions are expected to clarify and in some cases tighten the conditions on Indian management and beneficial ownership disclosure, reflecting supervisory concerns about indirect control arrangements.
2. Effective control and key personnel requirements. Across both insurance companies and intermediaries, the 2026 cycle includes provisions on effective control and key personnel composition that go beyond the formal shareholding limits. The intent is to ensure that the senior management, the board, and the critical operational functions are appropriately Indianised even where foreign capital is the majority owner. Broker firms with foreign parent ownership should review their board, executive, and key function composition against the anticipated requirements and prepare for any necessary adjustments.
3. Implications for broker firm valuations and M&A. The FDI framework changes interact with the ongoing consolidation in the Indian broker market. Several foreign-headquartered broker groups have acquired or invested in Indian broker firms during 2023-2025, and the 2026 cycle clarifies the conditions under which such investments operate. Broker firm valuations in M&A transactions are sensitive to the FDI conditions in ways that go beyond the headline cap, and broker owners contemplating sale or capital raise should engage advisors familiar with the evolving framework rather than assuming continuity of the 2024-2025 conditions.
4. Capital adequacy and operating capacity. Foreign-owned broker firms typically have stronger capital adequacy and operating capacity than the domestic average, and the FDI framework changes are unlikely to disrupt the basic capital position of established foreign-owned brokers. The strategic question is more about operating model flexibility, the ability to deploy global tools and capabilities through the Indian operation, and the constraints on intra-group service arrangements that the regulatory framework imposes.

For Indian-owned broker firms, the FDI environment is relevant primarily in the context of strategic options. Several mid-sized Indian broker firms are considering foreign partnership or sale as a route to scale, while others are committed to remaining independent. The 2026 cycle does not foreclose any of these options but does add specificity to the conditions under which each is executed. Broker leadership teams should assess their long-term strategic direction and the FDI framework implications together rather than as separate analyses.

The distribution rule framework is governed by several IRDAI regulations including the IRDAI (Insurance Brokers) Regulations, 2018, the IRDAI (Registration of Corporate Agents) Regulations, 2015, the IRDAI (Appointment of Insurance Agents) Regulations, 2016, and the IRDAI (Payment of Commission) Regulations, 2023. The 2026 cycle of the Amendment Bill includes statutory underpinnings for distribution rule revisions that the regulator can subsequently operationalise through these regulations.

The specific revisions in scope reflect supervisory experience with the current distribution framework and the policy direction of broadening access to insurance through diverse distribution channels while maintaining customer protection and intermediary accountability.

1. Agent-broker boundary. The legal distinction between agents and brokers in the Indian framework is foundational. Agents represent insurers and place business with one (individual agent) or up to nine (corporate agent) insurers as principals. Brokers represent the policyholder and place business with multiple insurers in the client's interest. The 2026 cycle includes provisions clarifying the fiduciary expectations on each category, the disclosure obligations to policyholders, and the conditions under which an entity can hold both an agent and a broker licence (typically through separate corporate entities). The clarifications are intended to address ambiguity that has affected regulatory enforcement and consumer protection in specific cases.
2. Multi-insurer corporate agents. The corporate agent framework currently permits representation of up to nine insurers across life, non-life, and health. The 2026 cycle proposes refinements to the disclosure and customer experience obligations for multi-insurer corporate agents, ensuring that customers are clearly informed about the principal insurer relationships and the basis on which the agent presents specific product options. The refinements are particularly relevant for bancassurance channels, where multi-insurer corporate agency by banks has expanded significantly in recent years.
3. Digital and embedded distribution. The framework for digital and embedded insurance distribution has expanded through IRDAI circulars and sandbox arrangements in 2023-2025. The 2026 cycle provides statutory clarity on the licensing and conduct requirements for these channels, addressing the gap between innovative digital distribution and the traditional intermediary regulatory categories. The implications for established broker firms include both competitive pressure from new digital channels and opportunities to partner with or invest in digital distribution capability.
4. Conduct obligations and customer protection. Distribution conduct obligations including suitability assessment, disclosure of remuneration, free-look provisions, and grievance handling are reinforced in the 2026 cycle. The reinforcement aligns with the broader supervisory direction on conduct of business in financial services, drawing from RBI and SEBI conduct frameworks where applicable.
5. Web aggregators and lead aggregators. The 2026 cycle includes provisions affecting the web aggregator and lead aggregator categories, with implications for the commission and referral economics in retail distribution. Broker firms operating digital channels in parallel with traditional broking should assess whether the new framework affects their digital business model.

The net effect of the distribution rule revisions for established broker firms is a tighter conduct framework, increased disclosure obligations, and refined boundaries with adjacent intermediary categories. The framework does not undermine the broker model but does require operational discipline in execution. Broker firms that have invested in conduct frameworks, training, and operational quality during 2023-2025 will find the new framework manageable; broker firms that have operated with lighter conduct discipline face material adjustment work to align with the strengthened supervisory expectations.

The Insurance Ombudsman Rules, 2017 establish the Insurance Ombudsman scheme that provides an out-of-court redressal mechanism for insurance disputes, with the existing scheme covering claims and complaints up to INR 50 lakh in pecuniary jurisdiction across 17 ombudsman benches distributed geographically. The 2026 cycle of the Amendment Bill includes statutory provisions supporting an expansion of the ombudsman scheme that has been under consideration through 2025.

1. Bench expansion. The number of ombudsman benches is expected to increase to address the geographic coverage gaps in the current scheme. Several states with significant insurance activity have limited direct access to ombudsman benches, requiring policyholders to travel or to file complaints with benches in other states. The expansion will improve access while increasing the operational footprint of the scheme.

2. Pecuniary jurisdiction. The pecuniary limit is expected to increase from the current INR 50 lakh, bringing more commercial claims and complaints into ombudsman jurisdiction rather than into the consumer forums under the Consumer Protection Act 2019 or civil courts. The specific revised limit will be defined in the notified Rules, but values discussed in consultation papers have ranged up to INR 5 crore for certain categories of dispute.

3. Scope expansion. The scope of the ombudsman jurisdiction is expected to expand to cover certain dispute categories that currently fall outside the scheme, including specific intermediary-related complaints and certain disputes between policyholders and TPAs. The scope expansion increases the breadth of dispute resolution available without resort to court proceedings.

4. Implementation and operational support. The expanded scheme requires more ombudsmen, secretariat capacity, and information technology support for case management. The Bill provides statutory framework for the funding and operational arrangements that the expanded scheme will require, including funding contributions from participating insurers.

5. Implications for commercial brokers and their clients. The increased pecuniary jurisdiction is particularly material for commercial insurance, where claims and disputes frequently exceed the current INR 50 lakh limit and have therefore fallen outside ombudsman reach. Commercial brokers should advise clients on the option of ombudsman dispute resolution as part of their claims advocacy strategy, particularly for claims in the INR 50 lakh to INR 5 crore range where the new framework provides an accessible alternative to consumer forum or civil court proceedings. The strategic considerations include the speed of resolution (ombudsman proceedings are generally faster than court litigation), the cost (ombudsman proceedings do not impose the costs of court litigation), the procedural informality (ombudsman proceedings are more accessible than court proceedings), and the precedent value (ombudsman decisions do not create binding precedent in the way court decisions do).

6. Broker conduct in ombudsman matters. Brokers should be prepared to support clients in ombudsman proceedings, including helping to prepare the complaint, providing factual context, and where appropriate appearing alongside the client at hearings. The broker's role in this support is part of the claims advocacy value that defends commercial broking economics. Brokers should also ensure that their own conduct does not become the subject of ombudsman complaints, which can happen when client expectations are mismanaged or when the broker fails to advocate adequately for the client during the claim process.

7. Documentation and process discipline. The expanded ombudsman scheme increases the importance of disciplined documentation through the policy lifecycle, including underwriting submissions, policy issuance, premium collection, servicing interactions, and claims processing. The documentation that supports a sound ombudsman defence is similar to the documentation that supports a sound court defence, but the ombudsman process tends to weigh contemporaneous documentation more heavily than retrospective justification. Brokers and insurers should invest in documentation discipline as a routine operational matter rather than as a specific litigation preparation activity.

The ombudsman expansion is broadly favourable for commercial policyholders and for brokers who serve them well, providing a more accessible dispute resolution channel for mid-sized commercial claims. Brokers should integrate ombudsman strategy into their claims advocacy capability and should communicate the expanded option to clients during renewal and servicing interactions.

The combined implications of the 2026 cycle for broker firms span operational, commercial, and strategic dimensions. Broker leadership teams should develop an integrated response that addresses each dimension rather than treating individual provisions in isolation.

1. Regulatory tracking and influence. The Bill is at the parliamentary committee stage in 2026, with passage and notification timelines depending on legislative scheduling. Broker firms should track the official Bill text, the committee reports, and the IRDAI consultation papers that will operationalise the statutory framework through specific regulations. Industry associations including the Insurance Brokers Association of India play a coordinating role in representing broker views during the consultation process, and broker firms should engage with the association on the substantive positions.
2. Operating model review. The distribution rule revisions, the conduct obligations, and the expanded ombudsman scheme have direct implications for the broker operating model. Each broker firm should review its operating model against the anticipated framework, identifying areas of strength and areas of required investment. The review should cover the placement workflows, the servicing workflows, the claims advocacy capability, the conduct framework, the training and supervision arrangements, and the documentation discipline.
3. Composite insurer relationship management. The composite licence provision will eventually reshape the insurer market structure that brokers interact with, with significant insurer consolidations likely over the next five to ten years. Broker firms should anticipate this consolidation in their insurer relationship strategy, building deeper relationships with the insurer groups that are likely to emerge as composite insurers and ensuring that the broker firm is well positioned in those relationships.
4. FDI and strategic options assessment. The FDI framework refinements affect the strategic options available to broker firms including independent growth, foreign partnership, sale to a larger broker, and capital raise. Broker leadership teams should periodically assess their strategic direction and the implications of the regulatory framework for each option. Smaller broker firms in particular face strategic choices that the regulatory and competitive environment makes more pressing.
5. Commercial client communication. Commercial clients are interested in regulatory developments that affect their insurance relationships, and brokers should communicate the implications of the 2026 cycle to clients in accessible language. The communication can be done through periodic client briefings, written advisory notes on specific provisions, and integration of regulatory developments into renewal discussions. Clients value brokers who explain the regulatory environment as part of the advisory relationship, and the 2026 cycle provides a natural opportunity to demonstrate that capability.

The Indian broker market is at a moment where multiple structural changes are converging: the Bima Sugam transition is reshaping distribution economics, the IRDAI cyber security framework refresh is raising operational expectations, the DPDP framework is changing data handling requirements, and the Insurance Amendment Bill is updating the statutory foundation. Broker firms that engage with each of these constructively, invest in the capability they require, and communicate the implications effectively to clients will continue to compete well. Broker firms that treat any of these as discretionary face increasing competitive disadvantage that compounds over the rest of the decade. Commercial clients evaluating their broker relationships should look for brokers who demonstrate active engagement with the changing regulatory environment and who can articulate the implications for the client's specific situation. To explore how the Sarvada platform supports brokers and commercial clients through this evolving regulatory environment, Request Access.